Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2007
06/21/2007US20070143875 Polynucleotides and Other Molecules Associated With Plants
06/21/2007US20070143874 Rice hybrid XL730
06/21/2007US20070143873 Potassium channels
06/21/2007US20070143872 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
06/21/2007US20070143871 Non-human transgenic animal models for hepatocellular carcinoma
06/21/2007US20070143869 Endotoxin-nonresponsive model animal
06/21/2007US20070143868 Sperm Cell Processing and Preservation Systems
06/21/2007US20070143865 Methods of screening agents for activity using teleosts
06/21/2007US20070142627 Sugar-chain-altered anti-hm1.24 antibody
06/21/2007US20070142316 Antisense IAP oligonucleotides and uses thereof
06/21/2007US20070142315 stimulate Toll-like receptor 8 (TLR8); drug delivery; cancer, an allergic condition, asthma, airway remodeling, or immunodeficiency
06/21/2007US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture
06/21/2007US20070142295 Thrombopoietic compounds
06/21/2007US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade
06/21/2007US20070142280 Factor VII or VIIa-like molecules
06/21/2007US20070141708 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
06/21/2007US20070141707 Sponge toxins
06/21/2007US20070141706 Adenovirus packaging cell lines
06/21/2007US20070141705 Method for producing viral vectors
06/21/2007US20070141704 Cell fusions and methods of making and using the same
06/21/2007US20070141702 by manipulation of O2 tension, including manipulation of Ca2+ under high O2 tension and contacting oocytes with serine threonine kinase inhibitors under low O2 tension, isolating inner cell masses (ICMs) from the activated oocytes, and culturing the cells of the isolated ICMs under high O2 tension
06/21/2007US20070141699 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA).
06/21/2007US20070141698 Microbial protein expression system utilizing plant viral coat protein
06/21/2007US20070141690 Mutant saccharomyces cerevisiae strain utilizing xylose for ethanol production
06/21/2007US20070141687 Increase in stress tolerance with ascorbic acid during fermentation
06/21/2007US20070141685 Feedback-resistant mevalonate kinases
06/21/2007US20070141681 Process for the production of L-amino acids using strains of the Enterobacteriaceae family
06/21/2007US20070141680 Malate quinone oxidoreductases; fermentatively preparing amino acids, especially L-lysine, L-tryptophan and L-proline
06/21/2007US20070141677 Genetic immunization with cationic lipids
06/21/2007US20070141670 Mammalian cytokine-like polypeptide-10
06/21/2007US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2)
06/21/2007US20070141667 Biopolymer based on lactococcus lactis nrrl b-60656, process for culturing lactocuccus lactis nrrl b-30656, and process for preparing the biopolymer
06/21/2007US20070141666 Leader sequences for use in production of proteins
06/21/2007US20070141665 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors
06/21/2007US20070141661 Cell extract for high-functioned cell-free protein synthesis and method of preparing the extract
06/21/2007US20070141644 G protein coupled receptor specific immunoglobulin for use in treatment and prevention of cell proliferative, cardiovascular and metabolic disorders
06/21/2007US20070141642 Guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37
06/21/2007US20070141622 Buffers for electrophoresis and use thereof
06/21/2007US20070141611 siRNA targeting spleen tyrosine kinase
06/21/2007US20070141602 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response
06/21/2007US20070141601 siRNA targeting cAMP-specific phosphodiesterase 4D
06/21/2007US20070141592 Thermostable reverse transcriptases and uses thereof
06/21/2007US20070141590 Modulators of tissue regeneration
06/21/2007US20070141589 Gene expression profiling in biopsied tumor tissues
06/21/2007US20070141588 Gene expression profiling in biopsied tumor tissues
06/21/2007US20070141587 Gene expression profiling in biopsied tumor tissues
06/21/2007US20070141586 Abasic site endonuclease assay
06/21/2007US20070141579 MUM-1 protein expressed by multiple myeloma-related gene
06/21/2007US20070141578 LuxO-sigma54 interactions and methods of use
06/21/2007US20070141574 Method for identifying a biosynthetic pathway gene product
06/21/2007US20070141573 Complement inhibitors
06/21/2007US20070141557 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein
06/21/2007US20070141556 Method for immobilizing a biomolecule on a solid substrate at a high density by using the substrate having an active carboxyl group on a surface thereof and microarray produced using the method
06/21/2007US20070141164 Methods and gel compositions for encapsulating living cells and organic molecules
06/21/2007US20070141134 Shielded micelles for polynucleotide delivery
06/21/2007US20070141088 Glucan-based vaccines
06/21/2007US20070141087 Compounds and methods for diagnosis of tuberculosis
06/21/2007US20070141085 Recombinant protective protein from Streptococcus pneumoniae
06/21/2007US20070141082 Cell surface expression vector of parvovirus antigen and microorganisms transformed thereof
06/21/2007US20070141081 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans
06/21/2007US20070141076 Antigen fragments for the diagnosis of Toxoplasma gondii
06/21/2007US20070141075 Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays
06/21/2007US20070141072 Use of multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes
06/21/2007US20070141065 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation
06/21/2007US20070141048 Using multiplex overlap-extension reverse transcriptase polymerase chain reaction to combine two or more nucleotide sequences encoding domains or subunits of heteromeric protein in a single reaction
06/21/2007US20070141038 Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site
06/21/2007US20070141029 Methods of gene therapy for treating disorders of the ear by adminstering a vector encoding an antonal-associated factor
06/21/2007US20070141028 Cancer gene therapeutic drug
06/21/2007US20070141009 Sirna mediated post-transriptional gene silencing of genes involved in alopecia
06/21/2007US20070140989 Protein with activity of hydrolyzing dextran, starch, mutan, inulin and levan, gene encoding the same, cell expressing the same, and production method thereof
06/21/2007US20070138014 Buffers for electrophoresis and use thereof
06/21/2007DE102004029112B4 Alkoholdehydrogenase zur stereoselektiven Gewinnung von Hydroxyverbindungen Alcohol for the stereoselective production of hydroxy
06/21/2007CA2634046A1 Micrornas that regulate muscle cell proliferation and differentiation
06/21/2007CA2633956A1 Binding proteins specific for insulin-like growth factors and uses thereof
06/21/2007CA2633468A1 Novel neurotrophic factor protein and uses thereof
06/21/2007CA2633296A1 Method of detecting and reducing boar taint using nuclear receptors
06/21/2007CA2633145A1 Constitutive plant promoters
06/21/2007CA2633087A1 Adenoviral expression vectors
06/21/2007CA2633062A1 Bydv mp is a viral determinant responsible for plant growth retardation
06/21/2007CA2632900A1 Hybrid 3' untranslated regions suitable for efficient protein expression in mammalian cells
06/21/2007CA2632837A1 Anti-myosin va sirna and skin depigmentation
06/21/2007CA2632762A1 Barley row type gene and use thereof
06/21/2007CA2632451A1 Cell penetrating peptides for intracellular delivery of molecules
06/21/2007CA2632142A1 Nuclear reprogramming factor
06/21/2007CA2631877A1 Method for detecting the presence or absence of a target cell in a sample
06/21/2007CA2631675A1 Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same
06/21/2007CA2604928A1 Methods for obtaining optically active epoxides and diols from 2,3-disubstituted and 2,3-trisubstituted epoxides
06/21/2007CA2569262A1 Hcv replicon shuttle vectors
06/20/2007EP1798651A1 Gene information display method and apparatus
06/20/2007EP1798288A2 Human Toll-like receptor proteins, related reagents and methods
06/20/2007EP1798287A2 Mammalian cell membrane proteins and related reagents
06/20/2007EP1798286A2 Mammalian cell membrane proteins and related reagents
06/20/2007EP1798285A1 Methods and medicament for inhibition the expression of a defined gene
06/20/2007EP1798243A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors
06/20/2007EP1798242A2 New anti-GF-IR antibodies and their applications
06/20/2007EP1798239A2 G-protein coupled receptors and uses therefor
06/20/2007EP1798214A1 Process for recovering statin compounds from a fermentation broth
06/20/2007EP1797897A1 Medicinal composition containing meltrin antagonist
06/20/2007EP1797894A2 Vaccine composition
06/20/2007EP1797886A2 Immune stimulation using chemically modified RNA